DRL launches Levalbuterol inhalation solution in the US
Gets approval from US FDA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Venus forays into Singapore’s topical pain management market
Gets marketing authorisation and patent for its herbal nanotechnology-based pain reliever Trois
Pfizer completes acquisition of InnoPharma
Pfizer has completed its acquisition of the pharmaceutical development company, InnoPharma, following receipt of United States…
Glenmark conferred with Civic Award 2013 -14
Recognised for exemplary initiatives in the area of CSR
Pharma Legal and Compliance Summit 2014 concludes in Mumbai
Leaders discuss legal issues and challenges related to the pharma industry at the event
Himalaya signs MoU with Andhra Pradesh Prisons Department
To expand the Prisoners’ Rehabilitation Programme to Central Prison, Visakhapatnam
Dyzle to showcase technology platform solution at 12th Annual Cold Chain GDP & Temperature…
Will address the concerns of cold chain and logistics managers
Indian pharma could gain from China-India MoUs
MoUs aimed at facilitating market access, cooperation on drug regulations could increase inroads into China pharma market
Ashland Pharmaceutical Centre of Excellence conducts training programmes
Training will help the channel partners from India and other parts of Asia to understand the technology
Merck Serono partners with Sutro Biopharma
Merck Serono to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline
Silver Leaf Oak acquires stake in Syngene International
Silver Leaf will acquire the stake from Biocon Research Limited (BRL), a wholly-owned subsidiary of Biocon at a valuation of Rs…
Cipla in agreement with Salix Pharmaceuticals
Cipla has granted Salix exclusive rights under certain patent applications in the ‘Rifaximin Complexes’ patent family
NPPA now cuts prices of anti-infectives, gastro and vaccines
Highest hit is ciprofloxacin 500 & 250 mg, which is 65 per cent of the market of the released CP.
Sun Pharma and Merck & Co in agreement
Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront…
AstraZeneca and Lilly in agreement
Announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease
Glenmark’s TRPA1 antagonist shows positive data in a proof of concept study
TRPA1 is an ion channel expressed on peripheral and spinal sensory neurons and it mediates pain signal transmission
Piramal Foundation supports J&K’s disaster relief operations
Piramal Sarvajal, Piramal Foundation’s philanthropic safe drinking water initiative to set up 10 water purification plants across…